RT Journal Article
SR Electronic
T1 Severity Prediction for COVID-19 Patients via Recurrent Neural Networks
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.28.20184200
DO 10.1101/2020.08.28.20184200
A1 Lee, Junghwan
A1 Ta, Casey
A1 Kim, Jae Hyun
A1 Liu, Cong
A1 Weng, Chunhua
YR 2021
UL http://medrxiv.org/content/early/2021/01/21/2020.08.28.20184200.abstract
AB The novel coronavirus disease-2019 (COVID-19) pandemic has threatened the health of tens of millions of people worldwide and imposed heavy burden on global healthcare systems. In this paper, we propose a model to predict whether a patient infected with COVID-19 will develop severe outcomes based only on the patient’s historical electronic health records (EHR) prior to hospital admission using recurrent neural networks. The model predicts risk score that represents the probability for a patient to progress into severe status (mechanical ventilation, tracheostomy, or death) after being infected with COVID-19. The model achieved 0.846 area under the receiver operating characteristic curve in predicting patients’ outcomes averaged over 5-fold cross validation. While many of the existing models use features obtained after diagnosis of COVID-19, our proposed model only utilizes a patient’s historical EHR to enable proactive risk management at the time of hospital admission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by The National Library of Medicine grant R01LM012895-03S1 and The National Center for Advancing Translational Science grant 1OT2TR003434-01.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Columbia University Institutional Review Boards.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data reference.